Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
114,09 €
-0,22 €
-0,19%
13:04:01 Uhr
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
66 %
Index-Zuordnung
Nasdaq Composite Index
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,41: VD9UEJ
Werbung

Illumina News

07.09.25 - PR Newswire
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
31.07.25 - PR Newswire
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 PR Newswire
30.07.25 - PR Newswire
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling PR Newswire
10.07.25 - PR Newswire
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 PR Newswire
10.07.25 - PR Newswire
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year PR Newswire
23.06.25 - PR Newswire
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy PR Newswire
10.06.25 wallstreetONLINE Redaktion
Aktie vor Turnaround?: Keine Geduld mehr mit Bayer und Evotec? Diese Aktie könnte die Lösung sein!
Turnaround-​Wetten kosten viel Zeit, Nerven – und oft auch Geld. Vor allem Evotec und Bayer enttäuschten zuletzt immer wieder. Deutlich aussichtsreicher könnte jetzt Gen- und ...
10.06.25 - PR Newswire
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics PR Newswire
10.06.25 - inv3st.de
Zukunftsmarkt - hier geht es um 50 Mrd. USD: Illumina, Moderna, PanGenomic Health
Medizin wird persönlich. Die Zeit, in der Medikamente allen helfen sollen, naht ihrem Ende. Die Experten von BCC Research gehen davon aus, dass der Markt für personalisierte ...
28.05.25 - PR Newswire
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies PR Newswire
14.05.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
13.05.25 - PR Newswire
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications PR Newswire
08.05.25 - PR Newswire
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 PR Newswire
01.05.25 - PR Newswire
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
Illumina and Ovation.io launching first-​of-kind GLP-1 dataset to accelerate new therapy development PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »